INTERNATIONAL PATENT: MUNA THERAPEUTICS APS FILES APPLICATION FOR "2-(TETRAHYDRO-2H-PYRAN-4-YL)-7-METHYL-8-OXO-6-(TRIFLUOROMETHYL)-7,8-DIHYDROPYRIMIDO[5,4-D]PYRIMIDINE DERIVATIVES AS TREM2 MODULATORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES"

GENEVA, July 14 -- MUNA THERAPEUTICS APS (Nordre Fasanvej 2152000 Frederiksberg) filed a patent application (PCT/EP2025/050086) for "2-(TETRAHYDRO-2H-PYRAN-4-YL)-7-METHYL-8-OXO-6-(TRIFLUOROMETHYL)-7,8-DIHYDROPYRIMIDO[5,4-D]PYRIMIDINE DERIVATIVES AS TREM2 MODULATORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES" on Jan 03, 2025. With publication no. WO/2025/146476, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BUSCH-PETERSEN, Jakob (c/o Muna Therapeutics ApSNordre Fasanvej 2152000 Frederiksberg), WHITLOCK, Gavin (Sande...